JP2005239660A - Precursor lipocyte differentiation promoter - Google Patents

Precursor lipocyte differentiation promoter Download PDF

Info

Publication number
JP2005239660A
JP2005239660A JP2004053462A JP2004053462A JP2005239660A JP 2005239660 A JP2005239660 A JP 2005239660A JP 2004053462 A JP2004053462 A JP 2004053462A JP 2004053462 A JP2004053462 A JP 2004053462A JP 2005239660 A JP2005239660 A JP 2005239660A
Authority
JP
Japan
Prior art keywords
fat
solvent
fat accumulation
present
precursor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004053462A
Other languages
Japanese (ja)
Inventor
Hidekazu Miyamoto
英和 宮本
Kimihiro Makino
公博 牧野
Kiyoshi Sugiyama
清 杉山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nicca Chemical Co Ltd
Original Assignee
Nicca Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicca Chemical Co Ltd filed Critical Nicca Chemical Co Ltd
Priority to JP2004053462A priority Critical patent/JP2005239660A/en
Publication of JP2005239660A publication Critical patent/JP2005239660A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Cosmetics (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To obtain a precursor lipocyte differentiation promoter having decomposability and locally accumulating fat to a part difficult to cause the fat accumulation. <P>SOLUTION: One or more kinds of extracts of plants selected from Citrus unshiu, Dioscorea tokoro, Diospyros kaki, Cinnamomum cassia, Paeonia lactiflora, Cnidium officinale, Polygonum multiflorum, Eriobotrya japonica and Actinidia polygama are used as a precursor lipocyte differentiation promoter. The extract is used as it is or in combination with other components as a food, drink, internal medicine, skin care preparation for external use, cosmetic, bathing agent, animal feed, or the like. <P>COPYRIGHT: (C)2005,JPO&NCIPI

Description

本発明は、脂肪蓄積促進剤、健康増進剤、美容剤、畜産飼料添加剤などとして有用な前駆脂肪細胞分化促進剤に関する。   The present invention relates to a preadipocyte differentiation promoter useful as a fat accumulation promoter, health enhancer, beauty agent, livestock feed additive and the like.

最近の健康や美容への関心の高まりから、老若男女を問わずに体を健康的で魅力的にしたいと願う人が増加している。   With the recent increase in interest in health and beauty, an increasing number of people want to make their bodies healthy and attractive regardless of gender.

なかでも、女性のバストに代表されるような女性らしいふくよかさを望む人が非常に多く、脂肪注入、シリコン注入などの美容外科的処置、エステティックサロンでの施術、サプリメントあるいは健康食品摂取などをしている。   Among them, there are very many people who want femininity such as a female bust, and do cosmetic surgery such as fat injection, silicone injection, esthetic salon treatment, supplement or health food intake. ing.

しかし、これまでに提案されている方法、薬剤、サプリメントなどによって得られる効果は、個人差が非常に大きく、満足な効果を有するものは見出されていない。さらに、美容形成外科やエステティックサロンでの施術は、非常に高価である上に、経時的な弊害(肌質悪化、型くずれなど)も懸念される。   However, the effects obtained by the methods, drugs, supplements, etc. proposed so far vary greatly from individual to individual, and no effect has been found. Furthermore, treatments in cosmetic plastic surgery and esthetic salons are very expensive and there are concerns over adverse effects over time (deterioration of skin quality, shape loss, etc.).

女性の乳房の90%は脂肪組織(細胞)から成ることが知られている。多くの女性が経験することであるが、食事制限によるダイエットやストレスなどのさまざまな要因により体重(体脂肪)が減少するときには、まず乳房が小さくなる。一方、摂取カロリー過剰により体重(体脂肪)が増加する際には、顔、腹回り、太股あるいは内臓に脂肪が蓄積するものの乳房に変化はあまりない。つまり、女性の乳房の大きさ、形などを特徴付けているのは脂肪組織(脂肪細胞)に蓄えられた脂肪の量及び質であって、その脂肪は非常に分解されやすく蓄積しにくいといえる。   It is known that 90% of female breasts are composed of adipose tissue (cells). As most women experience, when weight (body fat) decreases due to various factors such as diet and stress due to dietary restrictions, breasts first become smaller. On the other hand, when body weight (body fat) increases due to excess calorie intake, fat accumulates in the face, stomach, thighs, or internal organs, but the breast does not change much. In other words, it is the amount and quality of fat stored in adipose tissue (adipocytes) that characterizes the size and shape of a woman's breast, and it can be said that the fat is very easily decomposed and difficult to accumulate. .

本発明の課題は、非常に分解されやすく、蓄積しにくい部位の脂肪(脂肪組織)の局所蓄積を効率的に行うことを可能にする前駆脂肪細胞分化促進剤を提供することである。また、本発明はその前駆脂肪細胞分化促進剤を応用した、健康増進のための脂肪蓄積促進剤、女性らしいふくよかさを望む女性のための豊胸用剤、肌に張りを与える化粧品添加物、動物飼料添加物等を提供する。   An object of the present invention is to provide a preadipocyte differentiation promoting agent that enables efficient local accumulation of fat (adipose tissue) at a site that is very easily decomposed and difficult to accumulate. In addition, the present invention applies the preadipocyte differentiation promoter, a fat accumulation promoter for health promotion, a breast augmentation agent for women who want femininity, a cosmetic additive that gives skin tension, Provide animal feed additives.

本発明者らは、脂肪蓄積能を有する脂肪細胞は前駆脂肪細胞が分化したものである点に注目し、この分化を促進することが脂肪蓄積のために重要であると考え、前駆脂肪細胞の分化に関して鋭意研究を重ねた。その結果、特定の生薬が前駆脂肪細胞の分化を促進することを見出し、この知見により本発明を完成させるに至った。   The present inventors pay attention to the fact that fat cells having the ability to accumulate fat are differentiated from preadipocytes, and it is considered that promoting this differentiation is important for fat accumulation. We have earnestly studied on differentiation. As a result, it was found that a specific crude drug promotes differentiation of preadipocytes, and this finding has led to the completion of the present invention.

すなわち、本発明は、ウンシュウミカン、オニドコロ、カキ、ケイ、シャクヤク、センキュウ、ツルドクダミ、ビワ、マタタビから選ばれる植物の抽出物の1種又は2種以上を含有する前駆脂肪細胞分化促進剤を提供する。   That is, the present invention provides a preadipocyte differentiation promoter containing one or more of plant extracts selected from Satsuma mandarin, Onidokoro, Oyster, Kay, Peonies, Senkyu, Tsurugukudami, Loquat, and Matabi. .

ウンシュウミカン、オニドコロ、カキ、ケイ、シャクヤク、センキュウ、ツルドクダミ、ビワ、マタタビの抽出物には、前駆脂肪細胞の分化を促進する作用があり、有用である。これらは化粧品をはじめとする皮膚外用剤や浴用剤さらには飲食物に配合することによって、局所或いは全身の中性脂肪の蓄積を促進し、女性らしいふくよかさを望む女性のため胸を豊かにし、肌に張りを与えることができる。さらには、畜産用飼料をはじめとする畜産分野への応用も可能である。   Extracts of Satsuma mandarin, Onidokoro, Oyster, Kay, Peonies, Senkyu, Tsurugukudami, Biwa, and Matabi are useful because they have the effect of promoting the differentiation of preadipocytes. These are formulated into cosmetics and other skin external preparations, bath preparations, and food and drink to promote the accumulation of local or whole body neutral fat, enriching the breasts for women who want femininity, Can give skin tension. Furthermore, application to the livestock field including livestock feed is also possible.

本発明の前駆脂肪細胞分化促進剤は、ウンシュウミカン、オニドコロ、カキ、ケイ、シャクヤク、センキュウ、ツルドクダミ、ビワ、マタタビから選ばれる植物の抽出物の1種又は2種以上を含有するものである。   The preadipocyte differentiation promoting agent of the present invention contains one or more kinds of plant extracts selected from Satsuma mandarin, Onidokoro, Oyster, Kay, Peonies, Senkyu, Tsurudokudami, Biwa, and Matabi.

本発明において、これらの植物の各種部位を未乾燥のまま又は乾燥させた後、破砕又は粉砕後に溶媒で抽出して得られる抽出物や、該抽出物から抽出溶媒を蒸発、又は凍結乾燥して得られる不揮発分を使用することができる。   In the present invention, after various parts of these plants are left undried or dried, an extract obtained by extraction with a solvent after crushing or pulverization, or by evaporating or lyophilizing the extraction solvent from the extract The resulting non-volatile content can be used.

抽出溶媒としては、水、アルコール類(例えば、メタノール、エタノール、エチレングリコール、プロピレングリコール、1,3−ブチレングリコール等)、アセトンなどのケトン類、ジエチルエーテルなどのエーテル類、トルエンなどの芳香族類等の各種の溶剤が挙げられ、単独あるいは2種以上の混液を任意に組み合わせて使用することができる。   Examples of the extraction solvent include water, alcohols (eg, methanol, ethanol, ethylene glycol, propylene glycol, 1,3-butylene glycol, etc.), ketones such as acetone, ethers such as diethyl ether, and aromatics such as toluene. The various solvents, such as these, are mentioned, and can be used individually or in combination of 2 or more types.

本発明で使用するウンシュウミカン(Citrus unshiu)とは、ミカン科の植物であり、その実は広く食用とされている。本発明ではウンシュウミカンの幹、樹皮、葉、枝、枝葉、花、果実、果皮、種子、根、根皮を用いるが、他に同属植物を用いることもできる。最も好ましいのは、その果皮を乾燥した粉末を溶剤で抽出し溶媒を溜去して得られるものである。   Citrus unshiu used in the present invention is a plant of the citrus family and its fruit is widely used for food. In the present invention, the trunk, bark, leaves, branches, branches and leaves, flowers, fruits, pericarp, seeds, roots and root barks of Satsuma mandarin are used, but other plants belonging to the same genus can also be used. Most preferably, the powder obtained by drying the peel is extracted with a solvent and the solvent is distilled off.

本発明で使用するオニドコロ(Dioscorea tokoro)とは、ヤマノイモ科の植物である。本発明ではオニドコロの全草、葉、茎、花、果実、果皮、種子、根、根茎、根皮を用いるが、他に同属植物を用いることもできる。最も好ましいのは、その根茎を乾燥した粉末を溶剤で抽出し溶媒を溜去して得られるものである。   The term “Dioscorea tokoro” used in the present invention is a plant of the genus Dioscorea. In the present invention, the whole plant, leaves, stems, flowers, fruits, pericarps, seeds, roots, rhizomes, and root barks of Onidoro are used, but other plants belonging to the same genus can also be used. Most preferably, the powder obtained by drying the rhizome is extracted with a solvent and the solvent is distilled off.

本発明で使用するカキ(Diospyros kaki)とは、カキノキ科の植物であり、その実は広く食用とされている。本発明ではカキの幹、樹皮、葉、枝、枝葉、花、果実、果皮、種子、根、根皮を用いるが、他に同属植物を用いることもできる。最も好ましいのは、その葉を乾燥した粉末を溶剤で抽出し溶媒を溜去して得られるものである。   The oyster (Diospyros kaki) used in the present invention is a plant belonging to the family Oysteraceae, and its fruit is widely edible. In the present invention, oyster trunk, bark, leaves, branches, branches and leaves, flowers, fruits, pericarp, seeds, roots, root barks are used, but other plants belonging to the same genus can also be used. Most preferably, the powder obtained by drying the leaves is extracted with a solvent and the solvent is distilled off.

本発明で使用するケイ(Cinnamomum cassia)とは、クスノキ科の植物である。本発明ではケイの幹、幹皮、葉、枝、枝葉、花、果実、果皮、種子、根、根皮を用いるが、他に同属植物を用いることもできる。最も好ましいのは、その幹皮を乾燥した粉末を溶剤で抽出し溶媒を溜去して得られるものである。   Cinnamomum cassia used in the present invention is a plant belonging to the family Aceraceae. In the present invention, the trunk, trunk bark, leaves, branches, branches and leaves, flowers, fruits, pericarps, seeds, roots, root barks of the silk are used, but other genus plants can also be used. Most preferably, the powder obtained by drying the trunk skin is extracted with a solvent and the solvent is distilled off.

本発明で使用するシャクヤク(Paeonia lactiflora)とは、ボタン科の植物である。本発明ではシャクヤクの全草、葉、茎、花、果実、果皮、種子、根、根皮を用いるが、他に同属植物を用いることもできる。最も好ましいのは、その根を乾燥した粉末を溶剤で抽出し溶媒を溜去して得られるものである。   The peony (Paeonia lactiflora) used in the present invention is a plant of the Button family. In the present invention, peony whole plants, leaves, stems, flowers, fruits, pericarps, seeds, roots, root barks are used, but other plants belonging to the same genus can be used. Most preferably, it is obtained by extracting powder with dried roots with a solvent and distilling off the solvent.

本発明で使用するセンキュウ(Cnidium officinale)とは、セリ科の植物である。本発明ではセンキュウの全草、葉、茎、花、果実、果皮、種子、根、根茎、根皮を用いるが、他に同属植物を用いることもできる。最も好ましいのは、その根茎を乾燥した粉末を溶剤で抽出し溶媒を溜去して得られるものである。   The cucumber (Cnidium officinale) used in the present invention is a plant of the Apiaceae family. In the present invention, whole leaves, leaves, stems, flowers, fruits, pericarps, seeds, roots, rhizomes and root barks of senkyu are used, but other genus plants can also be used. Most preferably, the powder obtained by drying the rhizome is extracted with a solvent and the solvent is distilled off.

本発明で使用するツルドクダミ(Polygonum multiflorum)とは、タデ科の植物である。
本発明ではツルドクダミの全草、葉、茎、花、果実、果皮、種子、根、塊根、根皮を用いるが、他に同属植物を用いることもできる。最も好ましいのは、その塊根を乾燥した粉末を溶剤で抽出し溶媒を溜去して得られるものである。
Polygonum multiflorum used in the present invention is a plant belonging to the family Taceae.
In the present invention, the whole plant, leaves, stems, flowers, fruits, pericarps, seeds, roots, tuberous roots, and root barks of tsuldukudami are used, but other plants belonging to the same genus can also be used. Most preferably, the powder obtained by drying the tuberous root is extracted with a solvent and the solvent is distilled off.

本発明で使用するビワ(Eriobotrya japonica)とは、バラ科の植物である。本発明ではビワの幹、幹皮、葉、枝、枝葉、花、果実、果皮、種子、根、根皮を用いるが、他に同属植物を用いることもできる。最も好ましいのは、その葉を乾燥した粉末を溶剤で抽出し溶媒を溜去して得られるものである。   The loquat (Eriobotrya japonica) used in the present invention is a plant of the Rosaceae family. In the present invention, loquat trunk, stem bark, leaves, branches, branches and leaves, flowers, fruits, pericarps, seeds, roots, root barks are used, but plants belonging to the same genus can also be used. Most preferably, the powder obtained by drying the leaves is extracted with a solvent and the solvent is distilled off.

本発明で使用するマタタビ(Actinidia polygama)とは、マタタビ科の植物である。本発明ではマタタビの幹、樹皮、葉、枝、枝葉、花、果実、虫瘤、果皮、種子、根、根皮を用いるが、他に同属植物を用いることもできる。最も好ましいのは、その虫瘤を乾燥した粉末を溶剤で抽出し溶媒を溜去して得られるものである。   The matabi (Actinidia polygama) used in the present invention is a plant of the family Tabata. In the present invention, the trunk, bark, leaves, branches, branches and leaves, flowers, fruits, worms, pericarps, seeds, roots and root barks of matabha are used, but plants belonging to the same genus can also be used. Most preferably, the powder obtained by drying the aneurysm is extracted with a solvent and the solvent is distilled off.

本発明で使用される植物は、医薬または民間薬、食品、化粧品の成分として一般的に用いられているものであり、その安全性が確認されているものである。   The plant used in the present invention is one that is generally used as a component of medicine or folk medicine, food, and cosmetics, and its safety has been confirmed.

本発明の前駆脂肪細胞分化促進剤は、前記生薬の単独あるいは混合物を含有する。植物成分の総配合量は、剤型によっても異なるが、蒸発残分をそのまま使用しても構わないし、目的の用途によって適宜、配合量を調整すれば良い。本発明の前駆脂肪細胞分化促進剤の使用量は特に制限はなく、用途や適用により適宜調整することができる。   The preadipocyte differentiation promoter of the present invention contains the herbal medicines alone or as a mixture. Although the total blending amount of the plant component varies depending on the dosage form, the evaporation residue may be used as it is, and the blending amount may be appropriately adjusted depending on the intended use. There is no restriction | limiting in particular in the usage-amount of the preadipocyte differentiation promoter of this invention, It can adjust suitably with a use or application.

本発明の前駆脂肪細胞分化促進剤は、経口投与することも、経皮吸収させることもできる。したがって、飲食物、内用剤、化粧品をはじめとする各種の皮膚外用剤、浴用剤に製剤することができる。また、他の飲食物、医薬品、化粧品、浴用剤などに配合することもできる。   The preadipocyte differentiation promoting agent of the present invention can be administered orally or absorbed through the skin. Therefore, it can be formulated into various skin external preparations and bath preparations including foods and drinks, internal preparations and cosmetics. Moreover, it can also mix | blend with other food-drinks, a pharmaceutical, cosmetics, a bath agent, etc.

飲食物とする場合には、それ単独でもしくは他の飲食物に配合することができる。飲食物としては、いかなる形態であってもよく、例えばビスケット、クッキー、キャンディーのような固形のものでも、清涼飲料水のような液状のものでも、シロップであってもよい。成人1日当たりの摂取量が0.01〜5gとするのが適当であるが、適宜変更することが可能である。   In the case of a food or drink, it can be blended alone or in other food or drink. The food and drink may be in any form, and may be a solid such as biscuits, cookies, and candy, a liquid such as soft drinks, or a syrup. It is appropriate that the daily intake per adult is 0.01 to 5 g, but it can be changed as appropriate.

内用剤とする場合には、錠剤、カプセル剤、顆粒剤、散剤、シロップ剤等として製剤することができる。製剤するに当たっては、賦形剤、滑沢剤、結合剤、崩壊剤、コーティング剤のような担体とともに製剤することが出来る。必要に応じて、着色料、香料、防腐剤、香料を入れることもできる。内用する場合の1日当たりの量は、成人の場合抽出物の量で0.01〜5gとするのが適当であるが、適宜変更することが可能である。   When used as an internal preparation, it can be formulated as tablets, capsules, granules, powders, syrups and the like. In formulating, it can be formulated with a carrier such as an excipient, a lubricant, a binder, a disintegrant, and a coating agent. If necessary, coloring agents, fragrances, preservatives, and fragrances can be added. The amount per day for internal use is suitably 0.01 to 5 g in terms of the amount of extract for adults, but can be changed as appropriate.

外用剤とする場合にはペースト剤、クリーム、ジェル、軟膏、ローション、乳液、パック剤、パウダー、パップ剤等いかなる剤形であってもよい。その場合、公知のあらゆる基剤、賦形剤、担体を使用することができる。その場合の抽出物の含有量は、0.001〜50質量%とするのが適当である。浴用剤とする場合の抽出物の含有量は0.01〜50質量%とするのが適当である。   In the case of an external preparation, any dosage form such as paste, cream, gel, ointment, lotion, milky lotion, pack, powder, poultice may be used. In that case, all known bases, excipients, and carriers can be used. In that case, the content of the extract is suitably 0.001 to 50% by mass. The content of the extract when used as a bath agent is suitably 0.01 to 50% by mass.

さらに畜産用飼料の添加物として用いることができる。この場合は、従来の動物用飼料に適当量を添加する。   Furthermore, it can be used as an additive for livestock feed. In this case, an appropriate amount is added to the conventional animal feed.

以下、本発明を具体的に説明するために生薬抽出物に関する実施例および試験例を挙げ
るが、本発明はこれらの実施例に限定されるものではない。
Hereinafter, examples and test examples relating to herbal extracts will be described in order to specifically describe the present invention, but the present invention is not limited to these examples.

実施例1
ウンシュウミカンの果皮を乾燥した粉末50gを50質量%エタノール水を溶剤として抽出し溶媒を溜去して14.6gを得た。
Example 1
50 g of powder obtained by drying the peel of Citrus unshiu was extracted using 50% by mass ethanol water as a solvent, and the solvent was distilled off to obtain 14.6 g.

実施例2
オニドコロの根茎を乾燥した粉末50gを50質量%エタノール水を溶剤として抽出し溶媒を溜去して5.1gを得た。
Example 2
50 g of a powder obtained by drying Rhizome of Onidokoroko was extracted using 50% by mass ethanol water as a solvent, and the solvent was distilled off to obtain 5.1 g.

実施例3
カキの葉を乾燥した粉末50gを50質量%エタノール水を溶剤として抽出し溶媒を溜去して6.5gを得た。
Example 3
50 g of powder obtained by drying oyster leaves was extracted using 50% by mass ethanol water as a solvent, and the solvent was distilled off to obtain 6.5 g.

実施例4
ケイの幹皮を乾燥した粉末50gを50質量%エタノール水を溶剤として抽出し溶媒を溜去して5.0gを得た。
Example 4
50 g of powder obtained by drying the trunk of the silica was extracted using 50% by mass ethanol water as a solvent, and the solvent was distilled off to obtain 5.0 g.

実施例5
シャクヤクの根を乾燥した粉末50gを50質量%エタノール水を溶剤として抽出し溶媒を溜去して17.9gを得た。
Example 5
50 g of ethanol powder was extracted from 50 g of dried peony roots, and the solvent was distilled off to obtain 17.9 g.

実施例6
センキュウの根茎を乾燥した粉末50gを50質量%エタノール水を溶剤として抽出し溶媒を溜去して13.0gを得た。
Example 6
50 g of powder obtained by drying the rootstock of senkyu was extracted using 50% by mass ethanol water as a solvent, and the solvent was distilled off to obtain 13.0 g.

実施例7
ツルドクダミの塊根を乾燥した粉末50gを50質量%エタノール水を溶剤として抽出し溶媒を溜去して14.6gを得た。
Example 7
50 g of powder obtained by drying the roots of tsurudukudami was extracted using 50% by mass ethanol water as a solvent, and the solvent was distilled off to obtain 14.6 g.

実施例8
ビワの葉を乾燥した粉末50gを50質量%エタノール水を溶剤として抽出し溶媒を溜去して7.7gを得た。
Example 8
50 g of dry powder of loquat leaves was extracted using 50% by mass ethanol water as a solvent, and the solvent was distilled off to obtain 7.7 g.

実施例9
マタタビの虫瘤を乾燥した粉末50gを50質量%エタノール水を溶剤として抽出し溶媒を溜去して6.8gを得た。
Example 9
50 g of a powder obtained by drying the scab of Matatabi was extracted using 50% by mass ethanol water as a solvent, and the solvent was distilled off to obtain 6.8 g.

実施例10
実施例1〜9で得られた抽出物のそれぞれ0.01gを80℃の湯に溶かし、ゼリエース(ハウス食品)25gに加えて全体を100gとし、冷蔵庫で固化して9種類のゼリーとした。
Example 10
0.01 g of each of the extracts obtained in Examples 1 to 9 was dissolved in hot water at 80 ° C., added to 25 g of jelly (house food) to make 100 g as a whole, and solidified in a refrigerator to obtain 9 types of jelly.

実施例11
実施例1〜9で得られた抽出物のそれぞれ0.1g、ポリエチレングリコール20g、スクワラン5g、杏仁油3g、POE(12)ソルビタンモノオレエート2g、POE(10)硬化ひまし油1gに流動パラフィンを入れ全量を100gとし、9種類の浴用剤を得た。
Example 11
Liquid paraffin was added to 0.1 g of each of the extracts obtained in Examples 1 to 9, 20 g of polyethylene glycol, 5 g of squalane, 3 g of apricot oil, 2 g of POE (12) sorbitan monooleate, and 1 g of POE (10) hydrogenated castor oil. The total amount was 100 g, and 9 types of bath preparations were obtained.

実施例12
前駆脂肪細胞を用いた試験
(1)前駆脂肪細胞の培養と被験物質の添加
ヒューマンサイエンス振興財団研究資源バンクより分譲されたマウス前駆脂肪細胞株(3T3−L1)を用いて、規定の調製法に基づき、継代、分化させた。
Example 12
Test using preadipocytes
(1) Cultivation of preadipocytes and addition of test substances Using mouse preadipocyte cell line (3T3-L1) distributed by Research Resource Bank, Human Science Foundation, subculture and differentiate based on the prescribed preparation method It was.

規定の方法で継代した細胞をトリプシン処理することによりシャーレから剥がして細胞浮遊液を作製した。24ウェルプレートに細胞を播種した。培地は2日毎に交換し、細胞がコンフルエントになった後、さらに2日培養した。   Cells that had been passaged by a prescribed method were trypsinized to be detached from the petri dish to prepare a cell suspension. Cells were seeded in 24-well plates. The medium was changed every 2 days, and after the cells became confluent, the medium was further cultured for 2 days.

培地を除いて、各ウェルに分化誘導剤(インスリン、デキサメタゾン、イソブチルメチルキサンチン含有)を加えた培地を980μLずつ加えた。25及び5mg/mLの濃度で水−EtOH(1:1)に溶解した植物抽出物(乾燥品)を各ウェル当たり、20μL加えた。なお植物抽出物の最終濃度は0.5及び0.1mg/mLである。その後、インキュベーターに入れ2日培養した。培地を除き、各ウェルにインスリン含有培地を980μLずつ加えた。次に25及び5mg/mLの濃度で水−EtOH(1:1)に溶解した植物抽出物(乾燥品)を各ウェル当たり、20μL加え、インキュベーター中で2日培養した。   Except for the medium, 980 μL of medium supplemented with a differentiation inducer (containing insulin, dexamethasone, and isobutylmethylxanthine) was added to each well. 20 μL of plant extract (dried product) dissolved in water-EtOH (1: 1) at a concentration of 25 and 5 mg / mL was added to each well. The final concentration of the plant extract is 0.5 and 0.1 mg / mL. Thereafter, it was placed in an incubator and cultured for 2 days. The medium was removed, and 980 μL of insulin-containing medium was added to each well. Next, 20 μL of a plant extract (dried product) dissolved in water-EtOH (1: 1) at a concentration of 25 and 5 mg / mL was added to each well and cultured in an incubator for 2 days.

培地を除き、各ウェルに培地を980μLずつ加え、25及び5mg/mLの濃度で水−EtOH(1:1)に溶解した植物抽出物(乾燥品)を各ウェル当たり、20μL加え、インキュベーター中で2日培養した。   The medium was removed, 980 μL of medium was added to each well, and 20 μL of a plant extract (dried product) dissolved in water-EtOH (1: 1) at a concentration of 25 and 5 mg / mL was added to each well, and in an incubator. Cultured for 2 days.

(2)オイルレッドO染色試験
培地の除去後の96ウェルプレートをPBS(−)により洗浄し、そしてホルマリンを用いて固定後、細胞内に蓄積された脂肪粒をオイルレッドOを用いて染色した。オイルレッド染色した後、イソプロピルアルコールで色素を抽出し、脂肪を定量し、分化促進作用を評価した。
(2) Oil red O staining test The 96-well plate after removal of the culture medium was washed with PBS (−), fixed with formalin, and then fat particles accumulated in the cells were stained with oil red O. . After oil red staining, the pigment was extracted with isopropyl alcohol, the fat was quantified, and the differentiation promoting action was evaluated.

(3)GPDH活性測定試験
培地の除去後、PBS(−)により洗浄し、酵素抽出液と超音波破砕機で細胞破砕液をつくった。この破砕液から遠心により上清を得た。グリセロール−3−リン酸脱水素酵素(GPDH)活性測定キット(和光純薬)を用いて分化促進作用を評価した。GPDH活性の上昇は分化促進作用の指標となる。
(3) GPDH activity measurement After removing the test medium, it was washed with PBS (−), and a cell lysate was prepared with an enzyme extract and an ultrasonic crusher. A supernatant was obtained from this disrupted solution by centrifugation. Differentiation promoting action was evaluated using a glycerol-3-phosphate dehydrogenase (GPDH) activity measurement kit (Wako Pure Chemical Industries). An increase in GPDH activity serves as an indicator of differentiation promoting action.

Figure 2005239660
Figure 2005239660

表1に示すように、実施例1〜9の植物抽出物は前駆脂肪細胞が分化する過程において、オイルレッドOで染色される脂肪を増加させ、さらに分化において重要な役割を担うGPDH活性を上昇させることから、前駆脂肪細胞分化の促進作用を有することが明らかである。   As shown in Table 1, the plant extracts of Examples 1 to 9 increase fat stained with oil red O in the process of differentiation of preadipocytes, and further increase GPDH activity, which plays an important role in differentiation Therefore, it is clear that it has an effect of promoting differentiation of preadipocytes.

実施例13
動物を用いた試験
(1)ヘアレスマウスを用いた経皮投与試験
ヘアレスマウス(HR−1マウス)に一般飼育飼料を与えながら、実施例1〜9で得られた抽出物を1mg/kgの量で胴体に経皮投与した。これを20日間行い、各群を開腹して体脂肪量を目視で観察した。
Example 13
Animal testing
(1) Transdermal administration test using hairless mice While giving a general breeding feed to hairless mice (HR-1 mice), the extract obtained in Examples 1 to 9 was transdermally fed to the trunk in an amount of 1 mg / kg. Administered. This was performed for 20 days, and each group was opened and the amount of body fat was visually observed.

Figure 2005239660
Figure 2005239660

表2に示すように、実施例1〜9の植物抽出物はへアレスマウスへの経皮投与により体蓄積脂肪量を増加させ、脂肪蓄積効果があることは明らかである。   As shown in Table 2, it is clear that the plant extracts of Examples 1 to 9 increase the body accumulated fat amount by transdermal administration to hairless mice and have a fat accumulation effect.

(2)ICRマウスを用いた経口投与試験
ICRマウスに一般飼育飼料を与えながら、実施例1〜9で得られた抽出物を50mg/kgの量で経口投与した。これを20日間行い、各群を開腹して体脂肪量を目視で観察した。
(2) Oral administration test using ICR mice The extract obtained in Examples 1 to 9 was orally administered in an amount of 50 mg / kg while giving general breeding feed to ICR mice. This was performed for 20 days, and each group was opened and the amount of body fat was visually observed.

Figure 2005239660
Figure 2005239660

表3に示すように、実施例1〜9の植物抽出物はICRマウスへの経口投与により体蓄積脂肪量を増加させ、脂肪蓄積効果があることは明らかである。   As shown in Table 3, it is clear that the plant extracts of Examples 1 to 9 increase the body accumulated fat amount by oral administration to ICR mice and have a fat accumulating effect.

Claims (6)

ウンシュウミカン、オニドコロ、カキ、ケイ、シャクヤク、センキュウ、ツルドクダミ、ビワ、マタタビから選ばれる植物の抽出物の1種又は2種以上を含有する前駆脂肪細胞分化促進剤。   A preadipocyte differentiation promoter comprising one or more plant extracts selected from Satsuma mandarin, Onidokoro, Oyster, Kay, Peonies, Senkyu, Tsurudokudami, Biwa and Matabi. 請求項1記載の脂肪蓄積前駆脂肪細胞分化促進剤を含有する脂肪蓄積剤。   The fat accumulation agent containing the fat accumulation preadipocyte differentiation promoter of Claim 1. 請求項1記載の脂肪蓄積前駆脂肪細胞分化促進剤を含有する豊胸剤。   A breast augmenter containing the fat accumulation preadipocyte differentiation promoting agent according to claim 1. 請求項1記載の脂肪蓄積前駆脂肪細胞分化促進剤を含有する脂肪蓄積用および/または豊胸用皮膚外用剤。   A fat accumulation and / or breast augmentation skin external preparation containing the fat accumulation preadipocyte differentiation promoting agent according to claim 1. 請求項1記載の脂肪蓄積前駆脂肪細胞分化促進剤を含有する脂肪蓄積用および/または豊胸用浴用剤。   A fat accumulation and / or breast augmentation bath containing the fat accumulation preadipocyte differentiation promoting agent according to claim 1. 請求項1記載の脂肪蓄積前駆脂肪細胞分化促進剤を含有する脂肪蓄積用および/または豊胸用飲食物。   A fat-accumulating and / or breast-enhancing food or drink containing the fat-accumulating preadipocyte differentiation promoting agent according to claim 1.
JP2004053462A 2004-02-27 2004-02-27 Precursor lipocyte differentiation promoter Pending JP2005239660A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004053462A JP2005239660A (en) 2004-02-27 2004-02-27 Precursor lipocyte differentiation promoter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004053462A JP2005239660A (en) 2004-02-27 2004-02-27 Precursor lipocyte differentiation promoter

Publications (1)

Publication Number Publication Date
JP2005239660A true JP2005239660A (en) 2005-09-08

Family

ID=35021768

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004053462A Pending JP2005239660A (en) 2004-02-27 2004-02-27 Precursor lipocyte differentiation promoter

Country Status (1)

Country Link
JP (1) JP2005239660A (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008105985A (en) * 2006-10-25 2008-05-08 Nicca Chemical Co Ltd Hyaluronic acid production promoter, skin care preparation for external use, bathing agent, and food and drink
JP2008105983A (en) * 2006-10-25 2008-05-08 Nicca Chemical Co Ltd Fibroblast proliferation promoter, skin care preparation for external use, bathing agent, and food and drink
JP2009137846A (en) * 2007-12-04 2009-06-25 Kyoei Kagaku Kogyo Kk Cosmetic
JP2009545582A (en) * 2006-08-03 2009-12-24 セダーマ Sarsasapogenin-containing composition
JP2010184967A (en) * 2009-02-10 2010-08-26 Maruzen Pharmaceut Co Ltd Skin cosmetic and food and drink
JP2013032409A (en) * 2004-12-22 2013-02-14 Avon Products Inc Use of natural plant extract in cosmetic composition
JP2014023485A (en) * 2012-07-27 2014-02-06 Oju Seiyaku:Kk Loquat seed jelly and method for manufacturing the same
JP2016154562A (en) * 2016-06-06 2016-09-01 株式会社王樹製薬 Loquat-seed jelly and production method thereof
WO2021033994A1 (en) * 2019-08-16 2021-02-25 (주)유스케어팜 Composition comprising salvia miltiorrhiza or paeonia lactiflora extract as active ingredient for prevention or treatment of lipid metabolism disorder

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013032409A (en) * 2004-12-22 2013-02-14 Avon Products Inc Use of natural plant extract in cosmetic composition
JP2009545582A (en) * 2006-08-03 2009-12-24 セダーマ Sarsasapogenin-containing composition
JP2008105985A (en) * 2006-10-25 2008-05-08 Nicca Chemical Co Ltd Hyaluronic acid production promoter, skin care preparation for external use, bathing agent, and food and drink
JP2008105983A (en) * 2006-10-25 2008-05-08 Nicca Chemical Co Ltd Fibroblast proliferation promoter, skin care preparation for external use, bathing agent, and food and drink
JP2009137846A (en) * 2007-12-04 2009-06-25 Kyoei Kagaku Kogyo Kk Cosmetic
JP2010184967A (en) * 2009-02-10 2010-08-26 Maruzen Pharmaceut Co Ltd Skin cosmetic and food and drink
JP2014023485A (en) * 2012-07-27 2014-02-06 Oju Seiyaku:Kk Loquat seed jelly and method for manufacturing the same
JP2016154562A (en) * 2016-06-06 2016-09-01 株式会社王樹製薬 Loquat-seed jelly and production method thereof
WO2021033994A1 (en) * 2019-08-16 2021-02-25 (주)유스케어팜 Composition comprising salvia miltiorrhiza or paeonia lactiflora extract as active ingredient for prevention or treatment of lipid metabolism disorder

Similar Documents

Publication Publication Date Title
KR20090078203A (en) Peanut sprout extract, and food, cosmetic and medicinal composition containing it
JP2010143862A (en) Composition containing plant extract
JP6709783B2 (en) Composition for preventing hair loss or promoting hair growth containing alpine wormwood extract
JP2005239660A (en) Precursor lipocyte differentiation promoter
JP6843425B2 (en) Stem cell undifferentiated state maintainer and growth promoter
JP5819209B2 (en) Differentiation promoter from stem cells to brown adipocytes
JP6338107B2 (en) Skin barrier function improving agent, intercellular adhesion structure formation promoter, tight junction formation promoter, and TRPV4 gene expression enhancer
JP2017531645A (en) A composition for preventing hair loss or promoting hair growth, comprising an extract of scutellaria alpina
JP2005239659A (en) Precursor lipocyte differentiation inhibitor
JP2011102264A (en) Aromatase activator
JP2005220100A (en) Anti-ageing agent, platelet aggregation inhibitor, antioxidant, anti-allergic agent, skin cosmetic, and food and drink
JP6846106B2 (en) DKK1 expression promoter and whitening agent
JP5836421B2 (en) Hair growth composition, dermal papilla cell proliferation promoting composition, FGF-7 production promoting composition, VEGF production promoting composition, skin surface blood flow promoting composition and cosmetic
WO2016150310A1 (en) Topical composition containing galium aparine and method for brightening skin
JP2011126824A (en) Fat accumulation inhibitor
JP2011032177A (en) Inhibitor of kit cleavage
JP2014040487A (en) Fat accumulation inhibitor
KR20170025363A (en) Composition for improving skin
JP4585227B2 (en) Slimming kit
JP2017521411A (en) Whitening composition containing Scutellaria alpina extract
JP6017259B2 (en) Endothelin action inhibitor
JP7402509B2 (en) DKK1 expression promoter and whitening agent
JP2014114251A (en) Ceramide production promoter
JP7315940B2 (en) fibroblast growth factor-5 expression inhibitor
JP2019516777A (en) Whitening agent